ADVISORY-Alert incorrectly tagged to Curis Inc withdrawn
Reuters
Jan 13
ADVISORY-Alert incorrectly tagged to Curis Inc withdrawn
An alert on Danish drugmaker Curasight A/S CURAS.TE announcing preliminary data from the phase 1 trial for its drug, uTREAT, was inadvertently tagged to U.S.-based Curis Inc CRIS.O, an unrelated entity, and has been withdrawn.
There will be no substitute.
STORY_NUMBER: nTUA4WDPQN
STORY_DATE: January 12, 2026
STORY_TIME: 06:03 PM GMT
((Bangalore.newsroom@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.